Institute for Cancer Research, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea.
Int J Oncol. 2011 Jan;38(1):249-56.
We previously observed that TRAIL induces acquired TRAIL resistance coinciding with increased Akt phosphorylation brought about by the Src-PI3K-Akt signaling pathways and mediated by c-Cbl. c-Cbl, a ubiquitously expressed cytoplasmic adaptor protein, is simultaneously involved in the rapid degradation of TRAIL receptors and Akt phosphorylation during TRAIL treatment. Here, we show that Akt phosphorylation is not exclusively responsible for acquired TRAIL resistance. Akt catalytic activation is known to increase during metabolic oxidative stress, but we show that TRAIL also dramatically induces the catalytic activation of Akt in TRAIL-sensitive cells, but not in TRAIL-resistant cells. This suggests that Akt catalytic activation during TRAIL-induced apoptosis is likely to play a compensatory role in the maintenance of cell homeostasis. In addition, activated p38 and phosphorylated HSP27 were found to act as downstream effector molecules of p38 during TRAIL treatment and were shown to be responsible for increased Akt catalytic and invasive activities.
我们之前观察到,TRAIL 诱导获得性 TRAIL 耐药性,同时伴随着Src-PI3K-Akt 信号通路引起的 Akt 磷酸化增加,这一过程由 c-Cbl 介导。c-Cbl 是一种广泛表达的细胞质衔接蛋白,在 TRAIL 处理过程中,它同时参与 TRAIL 受体的快速降解和 Akt 磷酸化。在这里,我们表明 Akt 磷酸化并非获得性 TRAIL 耐药性的唯一原因。众所周知,Akt 的催化激活会在代谢性氧化应激期间增加,但我们表明,TRAIL 也会在 TRAIL 敏感细胞中显著诱导 Akt 的催化激活,但在 TRAIL 耐药细胞中不会。这表明,Akt 在 TRAIL 诱导的细胞凋亡过程中的催化激活可能在维持细胞内稳态方面发挥代偿作用。此外,我们发现激活的 p38 和磷酸化的 HSP27 在 TRAIL 处理过程中作为 p38 的下游效应分子发挥作用,并负责增加 Akt 的催化和侵袭活性。